Phio Pharmaceuticals Corp. ( PHIO) - Key Metrics
PHIO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.36 | -$0.35 | -$0.35 |
| 2026Q1 | $0 | -$0.34 | -$0.34 | -$0.34 |
| 2025Q4 | $0 | -$0.20 | -$0.18 | -$0.18 |
| 2025Q3 | $0 | -$0.44 | -$0.38 | -$0.38 |
| 2025Q2 | $0 | -$0.45 | -$0.53 | -$0.53 |
PHIO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.71 |
| 2026Q1 | 0% | -0.90 |
| 2025Q4 | 0% | -1.31 |
| 2025Q3 | 0% | -1.41 |
| 2025Q2 | 0% | -1.31 |
PHIO
Price: $0.85
52 week price:
Earnings Per Share: -1.28 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 90800
Market Capitalization: 11.6 million